159 related articles for article (PubMed ID: 21319998)
1. Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.
Giordano FA; Sorg UR; Appelt JU; Lachmann N; Bleier S; Roeder I; Kleff V; Flasshove M; Zeller WJ; Allgayer H; von Kalle C; Fruehauf S; Moritz T; Laufs S
Hum Gene Ther; 2011 Jun; 22(6):697-710. PubMed ID: 21319998
[TBL] [Abstract][Full Text] [Related]
2. Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression.
Ball CR; Pilz IH; Schmidt M; Fessler S; Williams DA; von Kalle C; Glimm H
Blood; 2007 Sep; 110(6):1779-87. PubMed ID: 17496202
[TBL] [Abstract][Full Text] [Related]
3. F2A sequence linking MGMT(P140K) and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells.
Maier P; Heckmann D; Spier I; Laufs S; Zucknick M; Allgayer H; Fruehauf S; Zeller WJ; Wenz F
Cancer Gene Ther; 2012 Nov; 19(11):802-10. PubMed ID: 23037811
[TBL] [Abstract][Full Text] [Related]
4. Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Baum C
DNA Repair (Amst); 2007 Aug; 6(8):1187-96. PubMed ID: 17482894
[TBL] [Abstract][Full Text] [Related]
5. Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.
Milsom MD; Williams DA
DNA Repair (Amst); 2007 Aug; 6(8):1210-21. PubMed ID: 17482893
[TBL] [Abstract][Full Text] [Related]
6. Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells.
Lin Y; Cheung P; Roth JC; Wilson DL; Gerson SL
Mol Ther; 2011 Jul; 19(7):1342-52. PubMed ID: 21304493
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
[TBL] [Abstract][Full Text] [Related]
8. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of MGMT(P140K) and alpha-L-iduronidase in primary hepatocytes from mucopolysaccharidosis type I mice enables efficient selection with metabolic correction.
Wang D; Worsham DN; Pan D
J Gene Med; 2008 Mar; 10(3):249-59. PubMed ID: 18076130
[TBL] [Abstract][Full Text] [Related]
10. O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues.
Sorg UR; Kleff V; Fanaei S; Schumann A; Moellmann M; Opalka B; Thomale J; Moritz T
DNA Repair (Amst); 2007 Aug; 6(8):1197-209. PubMed ID: 17499560
[TBL] [Abstract][Full Text] [Related]
11. Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model.
Phaltane R; Haemmerle R; Rothe M; Modlich U; Moritz T
Hum Gene Ther; 2014 Feb; 25(2):144-55. PubMed ID: 24218991
[TBL] [Abstract][Full Text] [Related]
12. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure.
Reese JS; Qin X; Ballas CB; Sekiguchi M; Gerson SL
J Hematother Stem Cell Res; 2001 Feb; 10(1):115-23. PubMed ID: 11276365
[TBL] [Abstract][Full Text] [Related]
13. Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression.
Falahati R; Zhang J; Flebbe-Rehwaldt L; Shi Y; Gerson SL; Gaensler KM
Mol Ther; 2012 Nov; 20(11):2180-9. PubMed ID: 22871662
[TBL] [Abstract][Full Text] [Related]
14. Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients.
Bowman JE; Reese JS; Lingas KT; Gerson SL
Mol Ther; 2003 Jul; 8(1):42-50. PubMed ID: 12842427
[TBL] [Abstract][Full Text] [Related]
15. In vivo selection of hematopoietic stem cells transduced at a low multiplicity-of-infection with a foamy viral MGMT(P140K) vector.
Cai S; Ernstberger A; Wang H; Bailey BJ; Hartwell JR; Sinn AL; Eckermann O; Linka Y; Goebel WS; Hanenberg H; Pollok KE
Exp Hematol; 2008 Mar; 36(3):283-92. PubMed ID: 18279716
[TBL] [Abstract][Full Text] [Related]
16. Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy.
Grund N; Maier P; Giordano FA; Appelt JU; Zucknick M; Li L; Wenz F; Zeller WJ; Fruehauf S; Allgayer H; Laufs S
Hum Gene Ther; 2010 Aug; 21(8):943-56. PubMed ID: 20210626
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trial of MGMT(P140K) Gene Therapy in the Treatment of Pediatric Patients with Brain Tumors.
Kramer B; Singh R; Wischusen J; Dent R; Rush A; Middlemiss S; Ching YW; Alexander IE; McCowage G
Hum Gene Ther; 2018 Aug; 29(8):874-885. PubMed ID: 29385852
[TBL] [Abstract][Full Text] [Related]
18. In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations.
Pollok KE; Hartwell JR; Braber A; Cooper RJ; Jansen M; Ragg S; Bailey BJ; Erickson LC; Kreklau EL; Williams DA
Hum Gene Ther; 2003 Dec; 14(18):1703-14. PubMed ID: 14670122
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.
Zhao H; Pestina TI; Nasimuzzaman M; Mehta P; Hargrove PW; Persons DA
Blood; 2009 Jun; 113(23):5747-56. PubMed ID: 19365082
[TBL] [Abstract][Full Text] [Related]
20. Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation.
Hacke K; Falahati R; Flebbe-Rehwaldt L; Kasahara N; Gaensler KM
Immunol Res; 2009; 44(1-3):112-26. PubMed ID: 19048410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
